Skip to content

Large proportion of gay and bisexual migrants with HIV acquire the virus after arrival in France

Focus and Blur/Shutterstock.com

Who is at risk of injectable treatment failure?

Professor Chloe Orkin presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

‘Real world’ injectable treatment halves patient dissatisfaction, with only two viral failures in first six months

Dr Celia Jonsson-Oldenbüttel presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

Increasing number of pregnancies in women who grew up with HIV

Ground Picture/Shutterstock.com

Survival prospects for older people with HIV plotted accurately by simple scoring system

Dr Maxime Hentzien presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

After viral rebound, dolutegravir-based treatment more likely to suppress HIV

Dr Andrew Hill presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention

Todd Correll presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

Rapid scale-up of PrEP in Ukraine this year, despite the war

Chernihiv AIDS Center after being hit by a missile. Image from Sergiy Antoniak's EACS Standard of Care meeting presentation.

People with HIV not getting medication to prevent heart disease, despite high risk

Nadine Jaschinski presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.